Michael Igoe

Devex
@AlterIgoe

Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.

Latest Articles

Devex World 2018, Yemen's local heroes, and disease elimination milestones: This week in development
14 Jun 2018

Attacks in Yemen highlight aid’s reliance on local staff, Paraguay and Ghana achieve health milestones, and Devex World charts a path from “beneficiaries” to “consumers.”

Q&A: The World Bank's human capital project targets better outcomes
13 Jun 2018

Devex spoke to Annette Dixon, vice president of human developement at the World Bank, about the institution's forthcoming human capital index, a growing body of research tying quality investments to economic growth, and what it all means for World Bank projects.

At Devex World, development leaders begin to embrace what they don't know
13 Jun 2018

Data and technology have opened unprecedented possibilities for development organizations to understand and connect with the people they serve. At Devex World, organizations at the cutting edge of a shift from "beneficiaries" to "consumers" see promise in a future where they — finally — don't have all the answers.

Q&A: PEPFAR architect Anthony Fauci on the initiative's transformational impact
8 Jun 2018

On the 15th anniversary of the creation of the U.S. President's Emergency Plan for AIDS Relief, Devex spoke to Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, about PEPFAR's impact on U.S. global health — and how the initiative can adapt to daunting new challenges in the fight against HIV and AIDS.

Insecurity in Yemen, European Development Days, and the Islamic Development Bank's new strategy: This week in development
7 Jun 2018

Aid groups cite critical security threats in Yemen, the Islamic Development Bank unveils a new strategy — and a new brand — and British Parliament members warn of damage to the U.K. aid “brand.”

15 years later, PEPFAR is still at war with a global epidemic
25 May 2018

On May 27, 2003, U.S. Congress authorized the largest-ever investment in a single disease in U.S. global health history. Fifteen years later, PEPFAR has saved millions of lives and transformed global development. But to end an epidemic, the flagship HIV/AIDS program will have to go even further — and advocates fear budget pressure could jeopardize the fight.

WHA confronts Ebola, AfDB gets industrial, and North Korea engagement fades: This week in development
24 May 2018

The World Health Assembly confronts a new Ebola outbreak, the African Development Bank channels South Korea, and engagement with North Korea fades.

World Bank staff warn about trying to do more, while getting paid less
23 May 2018

The World Bank staff association has weighed in on a proposal to reduce annual salary growth, arguing it could make the bank less competitive. Others say the World Bank's capital increase deal paints a picture of a bigger and better institution.

PEPFAR chief questions US approach to supply chain technical assistance
21 May 2018

Speaking at a congressional hearing on USAID's $9.5 billion global health supply chain project, U.S. Ambassador Deborah Birx raised questions about how effectively the $3 billion spent on technical assistance since 2009 has been deployed.

5 takeaways from the USAID supply chain hearings
18 May 2018

On Thursday, U.S. lawmakers held a hearing to examine the largest contract ever awarded by USAID, a $9.5 billion global health supply chain project managed by Chemonics International, which has encountered major setbacks.